I agree that this site is using cookies. You can find further informations here.
X
Hettle, Robert
55  results:
Search for persons X
?
1

A matching‐adjusted indirect comparison of acalabrutinib ve..:

Kittai, Adam S. ; Skarbnik, Alan ; Miranda, Miguel...
American Journal of Hematology.  98 (2023)  12 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
2

Survival Extrapolation Incorporating General Population Mor..:

Sweeting, Michael J. ; Rutherford, Mark J. ; Jackson, Dan...
Medical Decision Making.  43 (2023)  6 - p. 737-748 , 2023
Link: https://doi.org/10.1177/..
 
?
3

Cost-Effectiveness Analysis of Adjuvant Olaparib Versus Wat..:

Polyzoi, Maria ; Ekman, Mattias ; Reithmeier, Anja...
PharmacoEconomics - Open.  8 (2023)  2 - p. 277-289 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Association between event-free survival and overall surviva..:

Ostoros, Gyula ; Hettle, Robert ; Georgoulia, Nefeli...
Expert Review of Anticancer Therapy.  23 (2023)  12 - p. 1305-1313 , 2023
Link: https://doi.org/10.1080/..
 
?
5

Real-World Outcomes for First Line Next-Generation Hormonal..:

Hettle, Robert ; Mihai, Adela ; Lang, Shona H..
Future Oncology.  19 (2023)  36 - p. 2425-2443 , 2023
Link: https://doi.org/10.2217/..
 
?
6

P642: A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICA..:

Skarbnik, Alan ; Kittai, Adam ; Miranda, Miguel...
HemaSphere.  7 (2023)  S3 - p. e4236347 , 2023
Link: https://doi.org/10.1097/..
 
?
7

Patient‐centered outcomes in the POLO study of active maint..:

Kindler, Hedy L. ; Yoo, Hyun Kyoo ; Hettle, Robert...
Cancer.  129 (2023)  9 - p. 1411-1418 , 2023
Link: https://doi.org/10.1002/..
 
?
8

Author response to 'Comment on "Population-adjusted indirec..:

Hettle, Robert ; McCrea, Charles
Therapeutic Advances in Medical Oncology.  15 (2023)  - p. 175883592311685 , 2023
Link: https://doi.org/10.1177/..
 
?
9

Cost-effectiveness of olaparib versus routine surveillance ..:

Tan, David SP ; Chan, Jack Junjie ; Hettle, Robert...
Journal of Gynecologic Oncology.  32 (2021)  2 - p. , 2021
Link: https://doi.org/10.3802/..
 
?
10

Population-adjusted indirect treatment comparison of the SO..:

Vergote, Ignace ; Ray-Coquard, Isabelle ; Anderson, Daniel M....
European Journal of Cancer.  157 (2021)  - p. 415-423 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Population-adjusted indirect treatment comparison of mainte..:

Hettle, Robert ; McCrea, Charles ; Lee, Chee Khoon.
Therapeutic Advances in Medical Oncology.  13 (2021)  - p. 175883592110496 , 2021
Link: https://doi.org/10.1177/..
 
?
12

Exploring the Impact of Treatment Switching on Overall Surv..:

Evans, Rachel ; Hawkins, Neil ; Dequen-O'Byrne, Pascale...
Targeted Oncology.  16 (2021)  5 - p. 613-623 , 2021
Link: https://doi.org/10.1007/..
 
?
13

Patient-centred outcomes and effect of disease progression ..:

Friedlander, Michael ; Moore, Kathleen N ; Colombo, Nicoletta...
The Lancet Oncology.  22 (2021)  5 - p. 632-642 , 2021
Link: https://doi.org/10.1016/..
 
?
14

A Critical Appraisal and Recommendations for Cost-Effective..:

Gao, Wei ; Muston, Dominic ; Monberg, Matthew...
PharmacoEconomics.  38 (2020)  11 - p. 1201-1218 , 2020
Link: https://doi.org/10.1007/..
 
?
15

Cost-effectiveness of olaparib as a maintenance treatment f..:

Muston, Dominic ; Hettle, Robert ; Monberg, Matthew...
Gynecologic Oncology.  159 (2020)  2 - p. 491-497 , 2020
Link: https://doi.org/10.1016/..
 
1-15